During this 50-minute panel discussion at Advanced Therapies Integrates 2022, tranScrip's Founding and Senior Partner Flic Gabbay, joined other heathcare professionals to discuss what needs to be considered when progressing advanced therapies through the clinical phase of development to reach the marketplace.
Flic Gabbay | Founding and Senior Partner | tranScrip
William Scott | Scientific Director, Transplant Regenerative Medicine | Newcastle University Medical School
Miguel Forte | Chief Executive Officer | Bone Therapeutics
Agathe Guillot | Senior Regulatory Consultant | DLRC
Raja Sharif | Founder/Chief Executive Officer | ATMPS Ltd
Jimmy McBlane | Preclinical Assessor | MHRA